Immunoproteins refers to blood proteins that are involved in playing
a role in the functioning of the immune system. These proteins
possess an immunological activity against pathogenic organisms and
substances as they display an abnormal increase in blood
concentration thereby acting as a potential indicator in disease
diagnosis during an unhealthy state. The immunoproteins form an
integrated body system in cells, tissues or organs that helps to
neutralize the harmful effects of antigens. The immunoproteins also
helps in the diagnosis of several diseases that includes infectious
diseases, cardiovascular diseases and oncological conditions.
High
prevalence rates of chronic diseases to push the sales of the global
immunoprotein diagnostic testing market
The prime reason for growth in the demand for immunoprotein
diagnostic testing services is the increase in prevalence and
incidence rate of chronic diseases. According to WHO, the Global
Health Observatory (GHO) data suggests that around 1.6 million which
accounts up to 2.8% of the total deaths are caused due to diabetes.
Moreover, the 2012, lung cancer alone was responsible to cause about
1.6 million deaths according to the statistics mentioned in the WHO
report. To prevent such high mortality rates due to chronic disorders
demands early diagnosis and suitable diagnostic testing. This is
where the global immunoprotein diagnostic testing can serve a massive
population thereby fueling its own growth at global level.
Download
PDF Brochure of This Business Report @
https://www.coherentmarketinsights.com/insight/request-pdf/502
Increase in geriatric population coupled with high prevalence of
non- communicable diseases responsibe to propel the global
immunoprotein diagnostic testing market
The major factors responsible to drive the global immunoprotein
diagnostic testing market are the rise in geriatric population and
the high prevalence and incidence rates of chronic diseases.
According to WHO, the number of people suffering from Diabetes has
risen from 108 million in 1980 to 422 million in 2014, suggesting
rapid rise in the prevalence and incidence of diabetes. Moreover,
according to Global Health Observatory data published by WHO in 2017,
around 70% of global deaths accounting up to 39.5 million are caused
due to non- communicable diseases (NCD) such as cardiovascular
diseases, chronic lung diseases, cancers and diabetes.
Top Key Players :
The key players dominating the global immunoprotein diagnostic
testing market includes Abbott Laboratories, Inc., Abcam PLC, Agilent
Technologies, AdnaGen, BioMerieux, Enzo Life Sciences, Inc.,
Fujirebio Diagnostics, Inc., DiaSorin SPA, Roche, Randox Laboratories
and Thermo Fisher Scientific. These companies are able to hold their
position in the global immunoprotein diagnostic testing market due to
consequent advancement in technological aspects. For instance,
increasing sensitivity and ease of use while performing ELISA to
develop radioimmunoassay keeping in mind the cost effective terms so
as to make it accessible and affordable to a population that is
price- sensitive.
The chemiluminescent segment exhibits a rapid growth in the global
immunoprotein diagnostic testing that can be attributed to the wide
scope of application and ease of use
The global immunoprotein diagnostic testing market is segmented on
the basis of technology, test type, application and geographical
regions.
On the basis of Technology,
• Radioimmunoassay
• Immunoturbidity Assay
• Chemiluminescence Assay
• Immunoprotein Electrophoresis
• Enzyme- based Immunoassay
• Immunofluorescence Assay
On the basis of Test Type,
• C- reactive Protein Diagnostic Test
• Complement System Protein Diagnostic Test
• Prealbumin Diagnostic Test
• Hepatoglobin Diagnostic Test
• Immunoglobulin Diagnostic Test
• Free Light Chain Diagnostic Test
• Others
Request
For Customization of This Business Report @
https://www.coherentmarketinsights.com/insight/request-customization/502
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment